P63

P63
  • 文章类型: Journal Article
    巨细胞瘤(GCT)是一种良性,局部侵袭性肿瘤复发率高,常见于长骨和颌面部骨,非常罕见。由于案件很少,关于肿瘤的行为没有足够的信息。此外,这种侵袭性病变与常见的反应性巨细胞病变的区别至关重要,需要更多的研究。本研究涉及口腔GCT病例及其临床病理的文献综述,射线照相,和生化分析。尽管没有关于该病变的免疫组织化学特征的可用研究,这项研究是朝着这个方向迈出的第一步,以更好地区分这种肿瘤并确定可能的发病机制。
    Giant cell tumor (GCT) is a benign, locally aggressive neoplasm with a high recurrence rate with common occurrence in the long bone and the cases in the maxillofacial region bone are very rare. Due to the paucity of the cases, there is not enough information available regarding the behavior of the tumor. Also, the differentiation of this aggressive lesion with the commonly occurring reactive giant cell lesions is crucial and needs more research. This study is pertaining to the review of literature of the cases of GCT in the oral cavity with their clinicopathological, radiographic, and biochemical analyses. Although there are no available studies regarding the immunohistochemical characteristics of this lesion, this study is the first step in this direction to differentiate this tumor better and identify the possible pathogenesis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Letter
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    MicroRNAs(miRNAs)是调控人类超过30%基因的小RNA分子。最近的研究表明,miRNA在肿瘤发生中起着至关重要的作用。与正常组织相比,人类肿瘤中的大量miRNA表达不足。此外,实验表明,干扰miRNA加工可增强肿瘤发生。多项研究记录了miRNA在癌症中的因果作用,目前正在开发基于miRNA的抗癌疗法。这篇综述主要集中在两个关键点:(1)miRNA及其在人类癌症中的作用;(2)miRNA对肿瘤抑制因子的调控。本文综述了(一)miRNA对肿瘤抑制因子p53的调控,(b)miR-144/451簇在调节Itch-p63-Ago2途径中的关键作用,和(c)miRNA对PTEN的调节。还讨论了miRNA在癌症中的未来研究和前景。了解这些途径将为靶向miRNA调控的治疗性干预开辟道路。
    MicroRNAs (miRNAs) are small RNA molecules that regulate more than 30% of genes in humans. Recent studies have revealed that miRNAs play a crucial role in tumorigenesis. Large sets of miRNAs in human tumors are under-expressed compared to normal tissues. Furthermore, experiments have shown that interference with miRNA processing enhances tumorigenesis. Multiple studies have documented the causal role of miRNAs in cancer, and miRNA-based anticancer therapies are currently being developed. This review primarily focuses on two key points: (1) miRNAs and their role in human cancer and (2) the regulation of tumor suppressors by miRNAs. The review discusses (a) the regulation of the tumor suppressor p53 by miRNA, (b) the critical role of the miR-144/451 cluster in regulating the Itch-p63-Ago2 pathway, and (c) the regulation of PTEN by miRNAs. Future research and the perspectives of miRNA in cancer are also discussed. Understanding these pathways will open avenues for therapeutic interventions targeting miRNA regulation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    呼吸道病毒引起气道炎症,导致上皮损伤和修复。miRNA,包括miR-149-5p,调节不同的病理状况。我们的目的是确定miR-149-5p如何在调节促炎症IL-6和p63(气道上皮伤口修复的关键调节因子)中起作用。响应支气管(BEAS-2B)和肺泡(A549)上皮细胞中的病毒蛋白。BEAS-2B或A549细胞与聚(I:C,0.5µg/mL)持续48小时,或SARS-CoV-2刺突蛋白-1或2亚基(S1或S2,1μg/mL)持续24小时。miR-149-5p在用poly(I:C)攻击的BEAS-2B中受到抑制,与IL-6和p63上调相关。miR-149-5p在用poly(I:C)刺激的A549中下调;IL-6表达增加,但是p63蛋白水平检测不到。miR-149-5p在暴露于S1或S2的细胞中保持不变,而S1转染增加BEAS-2B细胞中IL-6的表达。miR-149-5p在BEAS-2B细胞中的异位过表达抑制了IL-6和p63mRNA水平,并抑制了poly(I:C)诱导的IL-6和p63mRNA表达。miR-149-5p直接抑制BEAS-2B细胞中的IL-6mRNA。因此,BEAS-2B细胞对聚(I:C)的反应不同,S1或S2与A549细胞比较。因此,miR-149-5p失调可能参与poly(I:C)刺激但不参与S1或S2刺激的BEAS-2B细胞中IL-6产生和p63表达的增加。
    Respiratory viruses cause airway inflammation, resulting in epithelial injury and repair. miRNAs, including miR-149-5p, regulate different pathological conditions. We aimed to determine how miR-149-5p functions in regulating pro-inflammatory IL-6 and p63, key regulators of airway epithelial wound repair, in response to viral proteins in bronchial (BEAS-2B) and alveolar (A549) epithelial cells. BEAS-2B or A549 cells were incubated with poly (I:C, 0.5 µg/mL) for 48 h or SARS-CoV-2 spike protein-1 or 2 subunit (S1 or S2, 1 μg/mL) for 24 h. miR-149-5p was suppressed in BEAS-2B challenged with poly (I:C), correlating with IL-6 and p63 upregulation. miR-149-5p was down-regulated in A549 stimulated with poly (I:C); IL-6 expression increased, but p63 protein levels were undetectable. miR-149-5p remained unchanged in cells exposed to S1 or S2, while S1 transfection increased IL-6 expression in BEAS-2B cells. Ectopic over-expression of miR-149-5p in BEAS-2B cells suppressed IL-6 and p63 mRNA levels and inhibited poly (I:C)-induced IL-6 and p63 mRNA expressions. miR-149-5p directly suppressed IL-6 mRNA in BEAS-2B cells. Hence, BEAS-2B cells respond differently to poly (I:C), S1 or S2 compared to A549 cells. Thus, miR-149-5p dysregulation may be involved in poly (I:C)-stimulated but not S1- or S2-stimulated increased IL-6 production and p63 expression in BEAS-2B cells.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:p63是参与多种生物学功能的转录因子。在肝脏中,TAp63亚型诱导肝细胞中的脂质积累。然而,肝脏TAp63在代谢功能障碍相关脂肪性肝炎(MASH)伴纤维化进展中的作用尚不清楚.
    方法:我们评估了不同饮食诱导的纤维化脂肪性肝炎小鼠模型中的肝p63水平。接下来,我们使用病毒遗传学方法操纵TAp63在饮食诱导的脂肪性肝炎伴纤维化的成年小鼠中的表达,并表征了疾病状况。最后,我们在肝脏TAp63过表达和敲低的小鼠中进行了蛋白质组学分析。
    结果:TAp63的水平,而不是ΔN同工型,在饮食诱导的纤维化脂肪性肝炎小鼠的肝脏中增加。在饲喂蛋氨酸和胆碱缺乏饮食(MCDD)以及胆碱缺乏和高脂饮食(CDHFD)的小鼠中,肝TAp63敲低的预防和干预策略均显着改善了饮食诱导的脂肪性肝炎和纤维化。小鼠肝脏TAp63的过表达加重了饲喂CDHFD的小鼠的肝脏状况。这些小鼠肝脏的蛋白质组学分析揭示了多种蛋白质和途径的改变,如氧化磷酸化,抗氧化活性,过氧化物酶体功能和LDL清除。
    结论:这些结果表明,肝脏TAp63在饮食诱导的脂肪性肝炎纤维化的进展中起关键作用,它的抑制作用改善了疾病。
    OBJECTIVE: p63 is a transcription factor involved in multiple biological functions. In the liver, the TAp63 isoform induces lipid accumulation in hepatocytes. However, the role of liver TAp63 in the progression of metabolic dysfunction-associated steatohepatitis (MASH) with fibrosis is unknown.
    METHODS: We evaluated the hepatic p63 levels in different mouse models of steatohepatitis with fibrosis induced by diet. Next, we used virogenetic approaches to manipulate the expression of TAp63 in adult mice under diet-induced steatohepatitis with fibrosis and characterized the disease condition. Finally, we performed proteomics analysis in mice with overexpression and knockdown of hepatic TAp63.
    RESULTS: Levels of TAp63, but not of ΔN isoform, are increased in the liver of mice with diet-induced steatohepatitis with fibrosis. Both preventive and interventional strategies for the knockdown of hepatic TAp63 significantly ameliorated diet-induced steatohepatitis with fibrosis in mice fed a methionine- and choline-deficient diet (MCDD) and choline deficient and high fat diet (CDHFD). The overexpression of hepatic TAp63 in mice aggravated the liver condition in mice fed a CDHFD. Proteomic analysis in the liver of these mice revealed alteration in multiple proteins and pathways, such as oxidative phosphorylation, antioxidant activity, peroxisome function and LDL clearance.
    CONCLUSIONS: These results indicate that liver TAp63 plays a critical role in the progression of diet-induced steatohepatitis with fibrosis, and its inhibition ameliorates the disease.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    p53是45年前发现的SV40大T抗原结合蛋白,由人类癌症中最常见的突变TP53基因编码。作为转录因子,p53受到丰富的翻译后修饰网络的严格调节,以执行其在肿瘤抑制中的多种功能。尽管早期研究建立了p53介导的细胞周期阻滞,凋亡,衰老是癌症发展的经典障碍,越来越多的p53新功能被发现,p53介导的抗肿瘤活性的范围大大扩大。这里,我们回顾了p53调控的不同层次的复杂性,以及代谢中p53通路的最新进展,铁性凋亡,豁免权,和其他有助于肿瘤抑制的。我们还讨论了如何激活p53功能,特别有效地抑制肿瘤生长而不损害癌症治疗的正常稳态的挑战。
    p53 was discovered 45 years ago as an SV40 large T antigen binding protein, coded by the most frequently mutated TP53 gene in human cancers. As a transcription factor, p53 is tightly regulated by a rich network of post-translational modifications to execute its diverse functions in tumor suppression. Although early studies established p53-mediated cell-cycle arrest, apoptosis, and senescence as the classic barriers in cancer development, a growing number of new functions of p53 have been discovered and the scope of p53-mediated anti-tumor activity is largely expanded. Here, we review the complexity of different layers of p53 regulation, and the recent advance of the p53 pathway in metabolism, ferroptosis, immunity, and others that contribute to tumor suppression. We also discuss the challenge regarding how to activate p53 function specifically effective in inhibiting tumor growth without harming normal homeostasis for cancer therapy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    犁鼻器官(VNO)是附属嗅觉系统的一部分,检测信息素和触发一系列性行为和社会行为的化学因素。犁鼻上皮(VNE)与主要嗅觉上皮(MOE)的上皮具有几个特征。然而,它是一个独特的神经上皮,由化学感觉神经元组成,在细胞结构上不同于嗅觉感觉神经元,受体表达,和连通性。啮齿动物的犁鼻器官包括感觉上皮(SE)和形态上类似于呼吸上皮的薄的非感觉上皮(NSE)。Sox2阳性细胞先前已被鉴定为在MOE和VNE中产生神经元祖细胞的干细胞群。此外,MOE还包括p63阳性水平基底细胞,第二个静止干细胞池,对损伤有反应。针对转录因子p63,角蛋白-5(Krt5)的免疫标记,Krt14,NrCAM,Krt5Cre示踪实验强调了沿VNOSE基底层分布的水平基底细胞的存在。单细胞测序和遗传谱系追踪表明,犁鼻水平基底细胞来自边缘区附近SE和NSE之间边界的基底祖细胞。此外,我们的实验表明,啮齿动物的NSE是,像呼吸上皮一样,p63/Krt5基底祖细胞自我复制并产生面向VNO内腔的顶端柱状细胞的复层上皮。
    The vomeronasal organ (VNO) is a part of the accessory olfactory system, which detects pheromones and chemical factors that trigger a spectrum of sexual and social behaviors. The vomeronasal epithelium (VNE) shares several features with the epithelium of the main olfactory epithelium (MOE). However, it is a distinct neuroepithelium populated by chemosensory neurons that differ from the olfactory sensory neurons in cellular structure, receptor expression, and connectivity. The vomeronasal organ of rodents comprises a sensory epithelium (SE) and a thin non-sensory epithelium (NSE) that morphologically resembles the respiratory epithelium. Sox2-positive cells have been previously identified as the stem cell population that gives rise to neuronal progenitors in MOE and VNE. In addition, the MOE also comprises p63 positive horizontal basal cells, a second pool of quiescent stem cells that become active in response to injury. Immunolabeling against the transcription factor p63, Keratin-5 (Krt5), Krt14, NrCAM, and Krt5Cre tracing experiments highlighted the existence of horizontal basal cells distributed along the basal lamina of SE of the VNO. Single cell sequencing and genetic lineage tracing suggest that the vomeronasal horizontal basal cells arise from basal progenitors at the boundary between the SE and NSE proximal to the marginal zones. Moreover, our experiments revealed that the NSE of rodents is, like the respiratory epithelium, a stratified epithelium where the p63/Krt5+ basal progenitor cells self-replicate and give rise to the apical columnar cells facing the lumen of the VNO.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    存在对能够可靠地预测BC的结果并且能够指导该疾病的管理的生物标志物的持续需要。在此设置中,我们旨在探讨转录因子P63在行根治性膀胱切除术的肌层浸润性膀胱癌(MIBC)患者中的预后价值.P63表达与临床病理特征(肿瘤分期、节点参与,固有肌层入侵的模式,乳头状结构,间生,伴随原位癌,淋巴管浸润,神经周浸润,在65例根治性膀胱切除术标本中测试了坏死)和分子亚型(基底和腔型肿瘤),并与癌症特异性生存率(CSS)和总生存率(OS)相匹配。P63阴性肿瘤显示出明显较高的固有肌层侵袭模式2的发生率(50%vs.14%,p=0.002)和变异组织学(45%vs.19%,p=0.022)与P63阳性相比。根据CK5/6和CK20的组合表达式(算法#1),P63阳性和P63阴性肿瘤大多为基底样和双阴性,分别(p=0.004)。使用算法#2,基于CK5/6和GATA3的组合表达,绝大多数肿瘤总体上和在每组中是腔内的(p=0.003)。P63阳性和P63阴性肿瘤的CSS和OS没有显著差异,但前者具有更长的操作系统趋势。尽管与具有负面预后潜力的病理特征相关,P63状态无法预测CSS和OS。那就是说,它可能有助于更好的MIBC分子分型。
    There is an ongoing need for biomarkers that could reliably predict the outcome of BC and that could guide the management of this disease. In this setting, we aimed to explore the prognostic value of the transcription factor P63 in patients with muscle-invasive bladder cancer (MIBC) having undergone radical cystectomy. The correlation between P63 expression and clinicopathological features (tumor stage, nodes involvement, patterns of muscularis propria invasion, papillary architecture, anaplasia, concomitant carcinoma in situ, lymphovascular invasion, perineural invasion, necrosis) and molecular subtyping (basal and luminal type tumors) was tested in 65 radical cystectomy specimens and matched with cancer-specific survival (CSS) and overall survival (OS). P63-negative tumors displayed significantly higher rates of pattern 2 of muscularis propria invasion (50% vs. 14%, p = 0.002) and variant histology (45% vs. 19%, p = 0.022) compared to P63-positive ones. According to the combined expression of CK5/6 and CK20 (Algorithm #1), P63-positive and P63-negative tumors were mostly basal-like and double-negative, respectively (p = 0.004). Using Algorithm #2, based on the combined expression of CK5/6 and GATA3, the vast majority of tumors were luminal overall and in each group (p = 0.003). There was no significant difference in CSS and OS between P63-positive and P63-negative tumors, but the former featured a trend towards longer OS. Though associated with pathological features harboring negative prognostic potential, P63 status as such failed to predict CSS and OS. That said, it may contribute to better molecular subtyping of MIBC.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    人乳头瘤病毒8型(HPV8),皮肤属β型HPV,患有遗传性皮肤疾病疣状表皮发育不良(EV)的患者在日晒部位具有共同致癌潜力。我们先前已经表明,负责上皮免疫监视的朗格汉斯细胞在感染部位大大减少,并且HPV8E7蛋白干扰CCAAT/增强子结合蛋白(C/EBP)β以抑制朗格汉斯细胞趋化因子CCL20。同时,然而,我们观察到EV病变严重浸润有炎症免疫细胞,这与HPV8E6转基因小鼠的情况相似。为了确定关键的炎症因子,我们使用了广泛的多重方法,发现单核细胞吸引趋化因子CCL2被HPV8E6而不是E7表达HaCaT细胞显著和强烈地诱导,其用作UV损伤的皮肤角质形成细胞的模型。来自表达HPV8E6的角质形成细胞的条件培养基在体外增强了CCL2受体(CCR2)依赖性单核细胞募集,和巨噬细胞在基质中占主导地位,但在体内EV病变的表皮区室中也检测到。HPV8E6对CCL2的诱导甚至强于促炎细胞因子TNF-α的刺激,HPV8E6和TNF-α均导致转录因子C/EBPα的实质性抑制。使用RNAi介导的敲低和过表达方法,我们证明了最近鉴定的C/EBPα/miR-203/p63通路在HPV8E6介导的CCL2诱导蛋白和转录水平的机制作用.在表达HPV8E6的器官型气-液界面培养物和体内病变EV表皮中证实了p63和CCL2的上皮共表达。总之,我们的数据表明,HPV8癌蛋白通过调节C/EBP因子依赖性通路,主动去调节表皮免疫稳态.虽然HPV8E7抑制了病毒持续所需的免疫监视,本研究提供的证据表明,E6涉及干性促进因子p63,以支持可能助长EV病变癌变的炎症微环境.
    Human papillomavirus type 8 (HPV8), a cutaneous genus beta HPV type, has co-carcinogenic potential at sun-exposed sites in patients suffering from the inherited skin disease epidermodysplasia verruciformis (EV). We had previously shown that Langerhans cells responsible for epithelial immunosurveillance were strongly reduced at infected sites and that the HPV8 E7 protein interferes with the CCAAT/enhancer-binding protein (C/EBP)β to suppress the Langerhans cell chemokine CCL20. At the same time, however, we observed that EV lesions are heavily infiltrated with inflammatory immune cells, which is similar to the situation in HPV8 E6 transgenic mice. To identify critical inflammatory factors, we used a broad multiplex approach and found that the monocyte attracting chemokine CCL2 was significantly and strongly induced by HPV8 E6 but not E7-expressing HaCaT cells, which were used as a model for UV-damaged skin keratinocytes. Conditioned media from HPV8 E6-expressing keratinocytes enhanced CCL2-receptor (CCR2)-dependent monocyte recruitment in vitro, and macrophages predominated in the stroma but were also detected in the epidermal compartment of EV lesions in vivo. CCL2 induction by HPV8 E6 was even stronger than stimulation with the proinflammatory cytokine TNF-α, and both HPV8 E6 and TNF-α resulted in substantial suppression of the transcription factor C/EBPα. Using RNAi-mediated knockdown and overexpression approaches, we demonstrated a mechanistic role of the recently identified C/EBPα/miR-203/p63 pathway for HPV8 E6-mediated CCL2 induction at protein and transcriptional levels. Epithelial co-expression of p63 and CCL2 was confirmed in HPV8 E6-expressing organotypic air-liquid interface cultures and in lesional EV epidermis in vivo. In summary, our data demonstrate that HPV8 oncoproteins actively deregulate epidermal immune homeostasis through modulation of C/EBP factor-dependent pathways. While HPV8 E7 suppresses immunosurveillance required for viral persistence, the present study provides evidence that E6 involves the stemness-promoting factor p63 to support an inflammatory microenvironment that may fuel carcinogenesis in EV lesions.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    脑膜瘤,一种常见的中枢神经系统肿瘤,是一种被广泛研究的脑膜肿瘤.根据世界卫生组织(WHO)2021年脑膜瘤分类,有15个亚型已分为1级,2级和3级。WHO1级脑膜瘤通常被归类为良性,而WHO2级和3级肿瘤被归类为恶性。孕激素受体和P63是常见的免疫组织化学标记,已被证明在诊断中有用,分级,和许多肿瘤如乳腺癌的预后,前列腺癌,和胃肠道肿瘤的组织病理学实践。已经报道了将这些免疫组织化学标记物应用于脑膜瘤的分级,并在非洲的报告中记录了它们的有用性,欧洲,北美,南美洲,和亚洲。这项研究,因此,试图确定这些发现是否适用于非洲人群中的脑膜瘤。
    对病态解剖学部门收到的脑膜瘤的结果和组织学诊断病例进行了10年审查,尼日利亚大学,埃努古.对孕激素受体(PgRs)和P63进行免疫染色,并将结果与组织学等级进行比较。
    在这项研究中评估了WHO三种级别的脑膜瘤。M:F比为1:1.4,峰值年龄为41-50岁(SD±16.54)。大多数病例为WHO1级(86.1%),而WHO2级和3级肿瘤分别为8%和5.9%,分别。纤维变体是最常见的亚型(27.1%)。孕激素受体和P63免疫阳性与脑膜瘤的WHO等级之间没有相关性(分别为P=0.112和P=0.138)。
    我们的研究表明,孕激素受体和P63免疫阳性与脑膜瘤的WHO等级无关。这可能是由于在本研究中看到的脑膜瘤的主要变异。这些发现表明,PgR拮抗剂可能不是无法手术的脑膜瘤患者的有效替代治疗方法。此外,P63免疫阳性可能不是管理我们人群脑膜瘤的足够分级工具。
    UNASSIGNED: Meningiomas, a common neoplasm of the central nervous system, is a widely studied meningeal tumor. According to the World Health Organization (WHO) 2021 classification of meningiomas, there are 15 subtypes that have been grouped into grades 1, 2, and 3. The WHO grade 1 meningiomas are generally grouped as benign while the WHO grades 2 and 3 tumors are grouped as malignant. Progesterone receptors and P63 are common immunohistochemical markers that have proven useful in the diagnosis, grading, and prognostication of many neoplasms such as breast carcinoma, prostate carcinoma, and gastrointestinal tumors in histopathology practice. The application of these immunohistochemical markers to the grading of meningiomas has been reported and their usefulness documented in reports from Africa, Europe, North America, South America, and Asia. This study, therefore, seeks to determine if these findings are applicable to the meningiomas seen in an African population.
    UNASSIGNED: A 10-year review of results and histologically diagnosed cases of meningiomas received in the Department of Morbid Anatomy, University of Nigeria, Enugu. Immunostaining for progesterone receptors (PgRs) and P63 were done and results compared with histologic grades.
    UNASSIGNED: The three WHO grades of meningioma were assessed in this study. M: F ratio was 1:1.4 and peak age was 41-50 years age range (SD ± 16.54). The majority of the cases were WHO grade 1 (86.1%) while the WHO grades 2 and 3 tumors were 8% and 5.9%, respectively. The fibrous variant was the most common subtype (27.1%). There was no correlation between progesterone receptor and P63 immunopositivity to the WHO grades of meningioma (P = 0.112 and P = 0.138, respectively).
    UNASSIGNED: Our study showed that progesterone receptors and P63 immunopositivity did not correlate with the WHO grades of meningiomas. This may be due to the predominant variant of meningioma seen in this study. These findings indicate that PgR antagonist may not be an effective alternative for treatment in patients with inoperable meningiomas. Furthermore, P63 immunopositivity may not be a sufficient grading tool for managing meningiomas in our population.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号